Prof G Markets: Nvidia’s Blowout Earnings & Stock Split + Britain’s Damaged Economy
The Prof G Pod with Scott Galloway
Innovative Health Care Company Making Strategic Moves
The company's innovative approach in transitioning from an ED to a hair loss company has proven beneficial, presenting itself as a new economy healthcare innovator. Its cost-effective pricing strategy, offering a drug without FDA approval, has enabled them to avoid FDA costs and tap into the rapidly growing GLP1 industry, which has contributed significantly to their success in the market.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
